SER

Serina Therapeutics, Inc.

SER · CIK 1708599 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$0M
20182024
Net Income−$11M
20182024
Operating CF−$17M
20182024
Free Cash Flow
20182024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2018↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue—$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit—$0.0B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.51$-13.72$-0.28———
EPS (Diluted)$-1.51$-13.72————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2018↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B—
Stockholders' Equity$0.0B$0.0B$-0.0B$-0.0B$-0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2018↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$0.0B$0.0B$-0.0B$0.0B
Capital Expenditures———$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
← Companies